Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Exanthema

• Evaluation of Two Varnishes on the Improvement of White Spot Lesions in Children
• Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%
• Clinical Evaluation of the Efficacy of SPR-G Barrier Coat Versus Fluoride Varnish Versus MI Paste in the Treatment of Early White Spot Lesions in Pediatric Patients
• A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash
• Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI
• Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
• Bioactive Glass in the Treatment of Enamel White Spot Lesions
• Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy
• Caries Prevention Potential of Pearl Powder Versus CPP-ACP on Enamel White Spot Lesions
• Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash
• Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor
• Treatment of Postorthodontic White Spot Lesions
• A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption
• Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
• Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
• 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX
• Vitamin D Supplementation in Polymorphic Light Eruption
• Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients
• FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema
• Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)
• Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash
• Calcipotriol and Polymorphic Light Eruption
• Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash
• Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
• Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
• Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
• Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer